These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31990287)

  • 1. Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion.
    Park SY; Matte A; Jung Y; Ryu J; Anand WB; Han EY; Liu M; Carbone C; Melisi D; Nagasawa T; Locascio JJ; Lin CP; Silberstein LE; De Franceschi L
    Blood; 2020 Jun; 135(23):2071-2084. PubMed ID: 31990287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease Events.
    Chadebech P; Bodivit G; Di Liberto G; Jouard A; Vasseur C; Pirenne F; Bartolucci P
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34208829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease.
    Kean LS; Manci EA; Perry J; Balkan C; Coley S; Holtzclaw D; Adams AB; Larsen CP; Hsu LL; Archer DR
    Blood; 2003 Dec; 102(13):4582-93. PubMed ID: 12933586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease.
    Faes C; Ilich A; Sotiaux A; Sparkenbaugh EM; Henderson MW; Buczek L; Beckman JD; Ellsworth P; Noubouossie DF; Bhoopat L; Piegore M; Renoux C; Bergmeier W; Park Y; Ataga KI; Cooley B; Wolberg AS; Key NS; Pawlinski R
    Blood; 2019 Jun; 133(23):2529-2541. PubMed ID: 30952675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Sickle Red Blood Cell Adhesion and its Associated Changes in Biomarkers by Sulfated Nonanticoagulant Heparin Derivative.
    Alshaiban A; Muralidharan-Chari V; Nepo A; Mousa SA
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):230-8. PubMed ID: 25601897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving treatment paradigms in sickle cell disease.
    Jagadeeswaran R; Rivers A
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):440-446. PubMed ID: 29222291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Marrow Transplantation after Nonmyeloablative Treosulfan Conditioning Is Curative in a Murine Model of Sickle Cell Disease.
    Devadasan D; Sun CW; Westin ER; Wu LC; Pawlik KM; Townes TM; Goldman FD
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1554-1562. PubMed ID: 29684562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion.
    Chang J; Shi PA; Chiang EY; Frenette PS
    Blood; 2008 Jan; 111(2):915-23. PubMed ID: 17932253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Marrow as a Hematopoietic Stem Cell Source for Gene Therapy in Sickle Cell Disease: Evidence from Rhesus and SCD Patients.
    Uchida N; Fujita A; Hsieh MM; Bonifacino AC; Krouse AE; Metzger ME; Donahue RE; Tisdale JF
    Hum Gene Ther Clin Dev; 2017 Sep; 28(3):136-144. PubMed ID: 28447889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of a preclinical total marrow irradiation conditioning-based bone marrow transplant model for sickle cell disease.
    Sargur Madabushi S; Fouda R; Ghimire H; Abdelhamid AMH; Lim JE; Vishwasrao P; Kiven S; Brooks J; Zuro D; Rosenthal J; Guha C; Gupta K; Hui SK
    Front Oncol; 2022; 12():969429. PubMed ID: 36147914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patrolling monocytes scavenge endothelial-adherent sickle RBCs: a novel mechanism of inhibition of vaso-occlusion in SCD.
    Liu Y; Zhong H; Bao W; Mendelson A; An X; Shi P; Chou ST; Manwani D; Yazdanbakhsh K
    Blood; 2019 Aug; 134(7):579-590. PubMed ID: 31076443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole blood viscosity and red blood cell adhesion: Potential biomarkers for targeted and curative therapies in sickle cell disease.
    Kucukal E; Man Y; Hill A; Liu S; Bode A; An R; Kadambi J; Little JA; Gurkan UA
    Am J Hematol; 2020 Nov; 95(11):1246-1256. PubMed ID: 32656816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
    Nader E; Romana M; Connes P
    Front Immunol; 2020; 11():454. PubMed ID: 32231672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities.
    Alramadhani D; Aljahdali AS; Abdulmalik O; Pierce BD; Safo MK
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered hematopoiesis in murine sickle cell disease.
    Blouin MJ; De Paepe ME; Trudel M
    Blood; 1999 Aug; 94(4):1451-9. PubMed ID: 10438733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium flux alterations in erythrocytes from sickle cell mice: The relevance of mean corpuscular volume.
    Almeida LEF; Smith ML; Kamimura S; Vogel S; Quezado ZMN
    Blood Cells Mol Dis; 2024 Jan; 104():102800. PubMed ID: 37951090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery.
    Leonard A; Bonifacino A; Dominical VM; Luo M; Haro-Mora JJ; Demirci S; Uchida N; Pierciey FJ; Tisdale JF
    Br J Haematol; 2019 Jul; 186(2):286-299. PubMed ID: 30972754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell membrane and density changes under ambient and hypoxic conditions in transgenic mice producing human sickle hemoglobin.
    Reilly MP; Chomo MJ; Obata K; Asakura T
    Exp Hematol; 1994 Jun; 22(6):501-9. PubMed ID: 8187846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Hematopoiesis in Sickle Cell Disease by Prospective Isolation of Stem and Progenitor Cells.
    Tolu SS; Wang K; Yan Z; Zhang S; Roberts K; Crouch AS; Sebastian G; Chaitowitz M; Fornari ED; Schwechter EM; Uehlinger J; Manwani D; Minniti CP; Bouhassira EE
    Cells; 2020 Sep; 9(10):. PubMed ID: 32987729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.